New mediums of technology must be utilized correctly to reap full benefits.
Chris Bryant
Advertisement
Vice President of Analytics and Insights Management, Array
Articles by Chris Bryant
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Roundup: Novartis & Abogen Enter Licensing and Option Agreement, AstraZeneca and Daiichi Sankyo Enter Clinical Collaboration with Summit Therapeutics
2
How a Shift Towards Oral Medications Impacts GLP-1s
3
Foghorn Therapeutics & Eli Lilly Halt Fhd-909 Development Following Phase I Data
4
Regeneron and Sanofi Expand Antibody Alliance with Four New Drugs
5